[go: up one dir, main page]

ATE142640T1 - Triterpenderivate und diese enthaltende endothelinrezeptor antagonisten - Google Patents

Triterpenderivate und diese enthaltende endothelinrezeptor antagonisten

Info

Publication number
ATE142640T1
ATE142640T1 AT94304165T AT94304165T ATE142640T1 AT E142640 T1 ATE142640 T1 AT E142640T1 AT 94304165 T AT94304165 T AT 94304165T AT 94304165 T AT94304165 T AT 94304165T AT E142640 T1 ATE142640 T1 AT E142640T1
Authority
AT
Austria
Prior art keywords
derivatives
triterpender
receptor antagonists
containing same
endothelin receptor
Prior art date
Application number
AT94304165T
Other languages
English (en)
Inventor
Toshiro Konoike
Yoshitaka Araki
Tetsuyoshi Hayashi
Kensuke Sakurai
Takehiko Tozyo
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of ATE142640T1 publication Critical patent/ATE142640T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C07C233/33—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/18—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94304165T 1993-06-11 1994-06-09 Triterpenderivate und diese enthaltende endothelinrezeptor antagonisten ATE142640T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14041693 1993-06-11

Publications (1)

Publication Number Publication Date
ATE142640T1 true ATE142640T1 (de) 1996-09-15

Family

ID=15268217

Family Applications (2)

Application Number Title Priority Date Filing Date
AT95112524T ATE165811T1 (de) 1993-06-11 1994-06-09 Zwischenprodukte für die herstellung von endothelinrezeptor-antagonist-triterpen-derivat n
AT94304165T ATE142640T1 (de) 1993-06-11 1994-06-09 Triterpenderivate und diese enthaltende endothelinrezeptor antagonisten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT95112524T ATE165811T1 (de) 1993-06-11 1994-06-09 Zwischenprodukte für die herstellung von endothelinrezeptor-antagonist-triterpen-derivat n

Country Status (11)

Country Link
US (2) US5463107A (de)
EP (2) EP0682009B1 (de)
JP (1) JP2724114B2 (de)
KR (1) KR100201015B1 (de)
CN (2) CN1041938C (de)
AT (2) ATE165811T1 (de)
DE (2) DE69410081T2 (de)
DK (1) DK0628569T3 (de)
ES (2) ES2094622T3 (de)
GR (1) GR3021952T3 (de)
TW (1) TW272974B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69410081T2 (de) 1993-06-11 1998-10-08 Shionogi & Co Zwischenprodukte für die Herstellung von Endothelinrezeptor-Antagonist-Triterpen-Derivaten
ATE245447T1 (de) * 1995-06-02 2003-08-15 Shionogi & Co Inhibitor von gehirnödemen
WO1997027314A1 (fr) * 1996-01-23 1997-07-31 Shionogi & Co., Ltd. Processus de production d'analogues d'acide oleanolique par la culture de racine pileuse
TWI232102B (en) * 2001-07-17 2005-05-11 Shionogi & Co A pharmaceutical formulation for injection
JP2007217438A (ja) * 2001-07-17 2007-08-30 Shionogi & Co Ltd 注射用医薬製剤
MXPA04008944A (es) * 2002-03-22 2004-11-26 Shionogi & Co Procedimiento para derivados de triterpeno.
WO2004108163A1 (ja) * 2003-06-04 2004-12-16 Shionogi & Co., Ltd. 低帯電性粉末の製造方法
TWI335335B (en) * 2004-03-24 2011-01-01 Shionogi & Co A novel crystal of a triterpene derivative
US8017793B2 (en) 2004-05-14 2011-09-13 Shionogi & Co., Ltd. Oxidation of alcohol with use of hydrogen peroxide and tungsten catalyst
WO2006077801A1 (ja) * 2005-01-18 2006-07-27 Shionogi & Co., Ltd. ミリセロン誘導体の製造方法
TW200731966A (en) * 2005-12-21 2007-09-01 Shionogi & Co A pharmaceutical composition or a method for treating ischemic stroke
US20070207989A1 (en) * 2006-03-03 2007-09-06 Savipu Pharmaceuticals Diterpene derivatives for the treatment of cardiovascular, cancer and inflammatory diseases
US7795306B2 (en) * 2006-03-03 2010-09-14 Inderjit Kumar Dev Triterpene derivatives for the treatment of cancer and inflammatory disease by inhibition of NF-κB
US7323476B2 (en) * 2006-03-03 2008-01-29 Savipu Pharmaceuticals Myriceric acid derivatives for the treatment of cancer, cardiovascular and inflammatory diseases
US20070243273A1 (en) * 2006-04-12 2007-10-18 Savipu Pharmaceuticals Reduction of the Deleterious Effects of Tobacco Smoking
US20080017207A1 (en) * 2006-07-18 2008-01-24 Savipu Pharmaceuticals Reduction of the Deleterious Effects of Tobacco Smoking by the Induction of Phase 2 Enzymes by Nerf2
US20080187608A1 (en) * 2007-02-05 2008-08-07 Savipu Pharmaceuticals Enriched fractions from clary sage for the treatment of cancer, cardiovascular and inflammatory diseases
US20090022821A1 (en) * 2007-07-17 2009-01-22 Inderjit Kumar Dev Compositions from wax myrtle for the treatment of cancer, cardiovascular and inflammatory diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2115665T3 (es) 1991-01-29 1998-07-01 Shionogi & Co Derivado de triterpeno.
DE69410081T2 (de) 1993-06-11 1998-10-08 Shionogi & Co Zwischenprodukte für die Herstellung von Endothelinrezeptor-Antagonist-Triterpen-Derivaten

Also Published As

Publication number Publication date
ES2116663T3 (es) 1998-07-16
KR100201015B1 (ko) 1999-06-15
US5463107A (en) 1995-10-31
EP0682009A2 (de) 1995-11-15
CN1070183C (zh) 2001-08-29
EP0682009A3 (de) 1997-02-05
US5587505A (en) 1996-12-24
DE69410081D1 (de) 1998-06-10
DE69410081T2 (de) 1998-10-08
EP0682009B1 (de) 1998-05-06
CN1041938C (zh) 1999-02-03
CN1215725A (zh) 1999-05-05
ATE165811T1 (de) 1998-05-15
EP0628569A1 (de) 1994-12-14
DE69400506D1 (de) 1996-10-17
JPH0753484A (ja) 1995-02-28
JP2724114B2 (ja) 1998-03-09
DK0628569T3 (da) 1996-09-30
ES2094622T3 (es) 1997-01-16
EP0628569B1 (de) 1996-09-11
TW272974B (de) 1996-03-21
CN1106368A (zh) 1995-08-09
DE69400506T2 (de) 1997-02-13
KR950000663A (ko) 1995-01-03
GR3021952T3 (en) 1997-03-31

Similar Documents

Publication Publication Date Title
ATE142640T1 (de) Triterpenderivate und diese enthaltende endothelinrezeptor antagonisten
ES2086270T5 (es) Metabolitos de terfenadina y sus isomeros opticamente puros para tratar trastornos alergicos.
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
DK1920764T3 (da) Fluprostenolisopropylester til anvendelse i behandling af glaukom og okulær hypertension
DE69713582D1 (de) Zimtsäurederivate und deren verwendung als integrin-antagonisten
EP0896533A4 (de) Pentafluorobenzensulfonamiden und analoge
ES2172580T3 (es) 1,3-oxatiolanos sustituidos con propiedades antiviricas.
ES2087038A1 (es) Nuevas piperidinas con actividad antagonista del paf.
ES2106531T3 (es) Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso.
BR8902929A (pt) Artigo vendavel
ATE161531T1 (de) Acridine-1,8-dionderivate als therapeutisches mittel
DK0573218T3 (da) 4-carboxyimidazolderivater som angiotensin-II antagonister og deres terapeutiske anvendelse
NO915021D0 (no) Nye metylenbisfosfonsyrederivater
ZA894397B (en) Analgesic phenothiazine derivatives
HU9400908D0 (en) Pharmaceutical compositions for treatng skin disorders
ATE110569T1 (de) Pharmazeutische zusammensetzung zur verbesserung von dysuria.
ATE205829T1 (de) Fibrinogen receptor antagonisten mit substituierten b-aminosäurenestern und diese enthaltende pharmazeutische präparate
FI923662A0 (fi) Terapeutiska medel.
IL101506A0 (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
DE59504374D1 (de) Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen
ES472208A1 (es) Procedimiento para la obtencion de nuevos derivados de 2- bencimidazol.
ATE92461T1 (de) Gegen die zerebrale insuffizienz wirksame verbindungen.
ITMI911095A1 (it) COMPOSIZIONI FARMACEUTICHE CONTENENTI L'ESTERE 4-(2 METILAMMINOETIL)1, 2- FENILENICODELLyACIDO 2-METILPROPANOICO PER IL TRATTAMENTO DELLA NEUROOTTICOPATIA GLAUCOMATOSA
ITMI932285A1 (it) Disolfuro chinolonico antibatterico
IT1244696B (it) Derivato chinolonico ad attivita' antibatterica e mucolitica

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee